STOK
Stoke Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:53 PM EDT
25.64USD-1.423%(-0.37)848,622
Pre-marketOct 2, 2026 9:15:30 AM EDT
26.50USD+1.884%(+0.49)
Loading…
Loading…
1.65B
Healthcare
Biotechnology
HQ
Bedford, MA, USA
117
Previous Close
$26.01
Beta
0.80
52-Week High
$40.22 2026-03-10
52-Week Low
$20.32 2025-11-05
SMA 50
$29.90
SMA 200
$31.65
Avg. Vol 10D
1.15M
Avg. Vol 30D
922,760
Avg. Vol 90D
863,668
Relative Vol
0.92
64.53M
48.45M
75.09%
11,150,236
23.01%
17.31
49%/51%
60.44%
52.40%
0.4100%
200,000
183
5,496
17,769
Nov 3, 2026 (29d)
STOK Profile
stoke is developing antisense oligonucleotide medicines that target rna splicing to increase gene expression for the treatment of severe genetic diseases.
STOK Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 25.50 | 2026-09-28 | +0.47% | -2.627 |
| 1M | 29.81 | 2026-09-04 | -14.06% | 0.908 |
| 3M | 32.43 | 2026-07-06 | -21.00% | 1.068 |
| 6M | 32.79 | 2026-04-06 | -21.87% | 0.848 |
| 1Y | 26.81 | 2025-10-06 | -4.44% | 0.800 |
| 2Y | 11.79 | 2024-10-04 | +117.30% | — |
| 5Y | 25.63 | 2021-10-05 | -0.04% | 1.338 |
STOK Stock Summary
Stoke Therapeutics, Inc. Common Stock (NASDAQ:STOK) stock price today is $25.62, and today's volume is 848,622. STOK is down 1.499% today. The 30 day average volume is 922,760. STOK market cap is $1.65B with 64.53M shares outstanding.